ANNOVIS BIO, INC. (ANVS)
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimers Disease 6-Month NDA Submission
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimers Disease 6-Month NDA Submission
📈 **POSITIVE** • Medium confidence analysis (73%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical